Strategies to Improve Delivery to Reservoirs as Targets for Long-Acting Antivirals - Adeniyi Olagunju, BPharm, MRes, PhD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Multipurpose Prevention Technologies (MPTs) For Prevention of HIV and Pregnancy - Sharon L. Hillier, PhD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Pharmacokinetics of mAbs in Prevention, Treatment and Cure of Viral Infections -Edmund Capparelli, PharmD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Optimization of Pharmacology Studies and DDIs in Pregnant and Lactating Individuals -Angela Colbers, PhD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Pharmacology Pearls for Managing Absorption and Swallowing Difficulties - Saye Khoo, MD, PhD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Age-Related Changes in Pharmacokinetics and Pharmacodynamics - Catia Marzolini, PharmD, PhD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

The Non-adherent Patient: A Good or Bad Candidate for CAB+RPV? - Jose Castillo-Mancilla, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Long-acting Cabotegravir for Treatment and Prevention - M. Boffito, MD, PhD, FRCP

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Long-acting Cabotegravir for Treatment and Prevention: When Are You Protected? - M. Boffito, MD, PhD, FRCP

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

What’s on the Horizon for Direct Acting Antivirals for Hepatitis B? - Jennifer Kiser, PharmD, PhD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Recent Developments in Antivirals Against Herpes Simplex Virus Infection - Scott H. James, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Pharmacology Considerations of Future ART/PrEP Regimens - Marta Boffito, MD, PhD, FRCP

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Session 2: Discussion with the Audience | International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

CON Healthcare Provider: Oral Daily and/or On Demand PrEP - Laura Waters, MD, FRCP

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

PRO Healthcare Provider: Long-Acting Injectables for PrEP - Steve Taylor, MBChB, FRCP, PhD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

#2: Pharmacokinetics of sotrovimab, a monoclonal antibody for early treatment of mild-to-moderate COVID-19 - Asma El-Zailik

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Managing HIV Patients with Limited Treatment Options - 2nd EU Series, Spanish Edition

Managing HIV Patients with Limited Treatment Options - EU Series 2022 Second Edition

Managing HIV Patients with Limited Treatment Options - 2nd EU Series, Italian Edition

Managing HIV Patients with Limited Treatment Options - EU Series 2022 Second Edition

Managing HIV Patients with Limited Treatment Options - 2nd EU Series, German Edition

Managing HIV Patients with Limited Treatment Options - EU Series 2022 Second Edition

MHPLTO Glasgow_Georg Behrens

Managing HIV Patients with Limited Treatment Options 2022

Community Experience - Susan Cole, FRSA

Nurses & Pharmacists HIV Clinical Forum 2022

Use of PROMS - Nurse's Perspective - Moses Shongwe, RN

Nurses & Pharmacists HIV Clinical Forum 2022

Sexual Health Communication – Nurse's Perspective - David Evans, OBE, NTF

Nurses & Pharmacists HIV Clinical Forum 2022

MHPLTO Glasgow_Saye Khoo

Managing HIV Patients with Limited Treatment Options 2022